EMBECTA CORP. (EMBC) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $600.00K; Additional Paid in CapitalUSD $83.60M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-292.60M; Retained Earnings (Accumulated Deficit)USD $-404.30M.
- 2026-03-31: Common Stock, Value, IssuedUSD $600.00K; Additional Paid in CapitalUSD $88.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-290.00M; Retained Earnings (Accumulated Deficit)USD $-424.70M.
- 2025-12-31: Common Stock, Value, IssuedUSD $600.00K; Additional Paid in CapitalUSD $81.80M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-284.40M; Retained Earnings (Accumulated Deficit)USD $-411.10M.
- 2025-09-30: Common Stock, Value, IssuedUSD $600.00K; Additional Paid in CapitalUSD $80.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-285.60M; Retained Earnings (Accumulated Deficit)USD $-445.60M.
EMBECTA CORP. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600.00K | $83.60M | $-292.60M | $-404.30M | $-612.70M | 3 month · $4.20M 9 month · $15.80M |
| 2026-03-31 | $600.00K | $88.00M | $-290.00M | $-424.70M | $-626.10M | 3 month · $5.70M 6 month · $11.60M |
| 2025-12-31 | $600.00K | $81.80M | $-284.40M | $-411.10M | $-613.10M | 3 month · $5.90M |
| 2025-09-30 | $600.00K | $80.00M | $-285.60M | $-445.60M | $-650.60M | 12 month · $31.60M |
| 2025-06-30 | $600.00K | $70.20M | $-283.30M | $-457.10M | $-669.60M | 3 month · $5.90M 9 month · $22.10M |
| 2025-03-31 | $600.00K | $65.00M | $-308.30M | $-493.50M | $-736.20M | 3 month · $7.30M 6 month · $16.20M |
| 2024-12-31 | $600.00K | $58.20M | $-319.70M | $-507.90M | $-768.80M | 3 month · $8.90M |
| 2024-09-30 | $600.00K | $52.50M | $-292.80M | $-498.60M | $-738.30M | 12 month · $26.30M |
| 2024-06-30 | $600.00K | $46.20M | $-306.30M | $-504.20M | $-763.70M | 3 month · $6.50M 9 month · $20.10M |
| 2024-03-31 | $600.00K | $39.70M | $-299.90M | $-510.00M | $-769.60M | 3 month · $6.50M 6 month · $13.80M |
| 2023-12-31 | $600.00K | $33.40M | $-297.50M | $-530.00M | $-793.50M | 3 month · $7.30M |
| 2023-09-30 | $600.00K | $27.90M | $-309.10M | $-541.10M | $-821.70M | 12 month · $21.50M |
| 2023-06-30 | $600.00K | $23.20M | $-294.70M | $-538.50M | $-809.40M | 3 month · $5.50M 9 month · $16.60M |
| 2023-03-31 | $600.00K | $18.10M | $-296.20M | $-545.10M | $-822.60M | 3 month · $5.60M 6 month · $11.10M |
| 2022-12-31 | $600.00K | $12.70M | $-298.90M | $-550.50M | $-836.10M | 3 month · $5.50M |
| 2022-09-30 | $600.00K | $10.00M | $-324.90M | $-577.10M | $-891.40M | 12 month · $10.00M |
| 2022-06-30 | $600.00K | $5.80M | $-298.00M | $-556.00M | $-847.60M | 3 month · $5.80M 9 month · $5.80M |
| 2022-03-31 | (m) | (m) | $-286.40M | (m) | $-967.50M | (m) |
| 2021-12-31 | (m) | (m) | $-279.30M | (m) | $550.50M | (m) |
| 2021-09-30 | (m) | (m) | $-270.50M | (m) | $594.30M | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | $576.70M | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | $580.70M | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | $585.80M | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $572.20M | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | $577.10M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |